| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Veracyte Inc (NASDAQ: VCYT)
VCYT Technical Analysis
2
| As on 9th Jun 2023 VCYT STOCK Price closed @ 25.84 and we RECOMMEND Buy for LONG-TERM with Stoploss of 24.03 & Strong Sell for SHORT-TERM with Stoploss of 31.16 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VCYTSTOCK Price
| Open | 26.21 | Change | Price | % |
| High | 26.21 | 1 Day | -0.06 | -0.23 |
| Low | 25.42 | 1 Week | -0.04 | -0.15 |
| Close | 25.84 | 1 Month | 3.55 | 15.93 |
| Volume | 480700 | 1 Year | -17.46 | -40.32 |
| 52 Week High 43.62 | 52 Week Low 15.31 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| VCYT Daily Charts |
VCYT Intraday Charts |
Whats New @ Bazaartrend |
VCYT Free Analysis |
|
|
VCYT Important Levels Intraday
| RESISTANCE | 27.36 |
| RESISTANCE | 26.87 |
| RESISTANCE | 26.57 |
| RESISTANCE | 26.27 |
| SUPPORT | 25.41 |
| SUPPORT | 25.11 |
| SUPPORT | 24.81 |
| SUPPORT | 24.32 |
VCYT Forecast May 2024
| 4th UP Forecast | 52.43 |
| 3rd UP Forecast | 43.9 |
| 2nd UP Forecast | 38.63 |
| 1st UP Forecast | 33.36 |
| 1st DOWN Forecast | 18.32 |
| 2nd DOWN Forecast | 13.05 |
| 3rd DOWN Forecast | 7.78 |
| 4th DOWN Forecast | -0.75 |
VCYT Weekly Forecast
| 4th UP Forecast | 38.37 |
| 3rd UP Forecast | 34.35 |
| 2nd UP Forecast | 31.87 |
| 1st UP Forecast | 29.38 |
| 1st DOWN Forecast | 22.30 |
| 2nd DOWN Forecast | 19.81 |
| 3rd DOWN Forecast | 17.33 |
| 4th DOWN Forecast | 13.31 |
VCYT Forecast2024
| 4th UP Forecast | 84.59 |
| 3rd UP Forecast | 65.75 |
| 2nd UP Forecast | 54.1 |
| 1st UP Forecast | 42.46 |
| 1st DOWN Forecast | 9.22 |
| 2nd DOWN Forecast | -2.42 |
| 3rd DOWN Forecast | -14.07 |
| 4th DOWN Forecast | -32.91 |
Veracyte Inc ( NASDAQ USA Symbol : VCYT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VCYT Business Profile
Veracyte, Inc. operates as a genomic diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to identify patients with benign thyroid nodules among those with indeterminate cytopathology results in order to rule out unnecessary thyroid surgery; Percepta Genomic Sequencing Classifier for lung cancer diagnosis; Envisia Genomic Classifier that help physicians to differentiate idiopathic pulmonary fibrosis from other interstitial lung diseases without the need for surgery; and Prosigna Breast Cancer Prognostic Gene Signature Assay test that informs next steps for patients with early-stage breast cancer, as well as provides cancer subtype classification information. It is also developing nasal swab test for early lung cancer detection; Percepta Genomic Atlas for genomic profiling information on small samples of the tumor biopsy; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has biopharmaceutical collaborations with Johnson & Johnson; Acerta Pharma; Loxo Oncology, Inc.; and Bayer AG. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California. Address: 6000 Shoreline Court, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service